Blog
Teleflex (TFX) Q4 Earnings and Revenues Miss Estimates
Teleflex (TFX) came out with quarterly earnings of $1.93 per share, missing the Zacks Consensus Estimate of $3.73 per share. This compares to earnings of $3.89 per share a year ago. These figures
Smucker (SJM) Q3 Earnings and Revenues Surpass Estimates
Smucker (SJM) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $2.27 per share. This compares to earnings of $2.61 per share a year ago. These figures are
Shake Shack (SHAK) Q4 Earnings Top Estimates
Shake Shack (SHAK) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.26 per share a year ago. These
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to a loss of $0.72 per share a year ago
Playtika Holding (PLTK) Tops Q4 Earnings and Revenue Estimates
Playtika Holding (PLTK) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.03 per share a year ago. These
United Parks & Resorts (PRKS) Lags Q4 Earnings and Revenue Estimates
United Parks & Resorts (PRKS) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.53 per share a year ago
Perrigo (PRGO) Q4 Earnings Lag Estimates
Perrigo (PRGO) came out with quarterly earnings of $0.77 per share, missing the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $0.93 per share a year ago. These figures are
Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue Estimates
Indivior Pharmaceuticals Inc. (INDV) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.32 per share a year
Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates
Kymera Therapeutics, Inc. (KYMR) came out with a quarterly loss of $0.97 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to a loss of $0.88 per share a year ago
International Seaways (INSW) Surpasses Q4 Earnings and Revenue Estimates
International Seaways (INSW) came out with quarterly earnings of $2.45 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $0.9 per share a year ago
Kimbell Royalty (KRP) Tops Q4 Earnings and Revenue Estimates
Kimbell Royalty (KRP) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to a loss of $0.1 per share a year ago. These
Hagerty, Inc. (HGTY) Q4 Earnings and Revenues Beat Estimates
Hagerty, Inc. (HGTY) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.02 per share a year ago. These
Hilton Grand Vacations (HGV) Q4 Earnings and Revenues Lag Estimates
Hilton Grand Vacations (HGV) came out with quarterly earnings of $0.88 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.49 per share a year ago
Hormel Foods (HRL) Surpasses Q1 Earnings and Revenue Estimates
Hormel Foods (HRL) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.35 per share a year ago. These
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.18 per share a year ago
Here's Why Tetra (TTEK) Is a Great 'Buy the Bottom' Stock Now
Shares of Tetra Tech (TTEK) have been struggling lately and have lost 9.6% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock
Frontdoor (FTDR) Q4 Earnings and Revenues Surpass Estimates
Frontdoor (FTDR) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.27 per share a year ago. These figures
GigaCloud Technology Inc. (GCT) Surpasses Q4 Earnings and Revenue Estimates
GigaCloud Technology Inc. (GCT) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.76 per share a year ago
Eos Energy Enterprises, Inc. (EOSE) Reports Q4 Loss, Misses Revenue Estimates
Eos Energy Enterprises, Inc. (EOSE) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $2.2 per share a year ago
Wall Street Analysts Think Tactile Systems Technology (TCMD) Could Surge 28.34%: Read This Before Placing a Bet
Shares of Tactile Systems Technology (TCMD) have gained 3.4% over the past four weeks to close the last trading session at $29.61, but there could still be a solid upside left in the stock if
Wall Street Analysts Think Palomar (PLMR) Could Surge 36.15%: Read This Before Placing a Bet
Shares of Palomar (PLMR) have gained 1.7% over the past four weeks to close the last trading session at $121.68, but there could still be a solid upside left in the stock if short-term price targets
Huron Consulting (HURN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Shares of Huron Consulting (HURN) have been struggling lately and have lost 21.2% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean
Bentley Systems, Incorporated (BSY) Q4 Earnings Meet Estimates
Bentley Systems, Incorporated (BSY) came out with quarterly earnings of $0.27 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.21 per share a year ago. These
Wall Street Analysts Believe Oric Pharmaceuticals (ORIC) Could Rally 58.43%: Here's is How to Trade
Shares of Oric Pharmaceuticals, Inc. (ORIC) have gained 22% over the past four weeks to close the last trading session at $13.4, but there could still be a solid upside left in the stock if
RE/MAX (RMAX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
A downtrend has been apparent in RE/MAX (RMAX) lately. While the stock has lost 5.6% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading


